Evidence map›Paper›PMID 32143678›Full record

ArticleImplementation science : IS2020

A qualitative study of design stakeholders' views of developing and implementing a registry-based learning health system.

Mary Dixon-Woods, Anne Campbell, Trillium Chang, Graham Martin, Alexandros Georgiadis, Veronica Heney, Sarah Chew, Aricca Van Citters, Kathryn A Sabadosa, Eugene C Nelson

Abstract read
In one paragraph

Article in Implementation science : IS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The role of co-production in Learning Health Systems.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mary Dixon-WoodsTHIS Institute, Department of Public Health and Primary Care, University of Cambridge, Cambridge Biomedical Campus, Clifford Allbutt Building, Cambridge, CB2 0AH, UK. director@thisinstitute.cam.ac.uk.ORCID 0000-0002-5915-0041
Anne CampbellThe NIHR Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Imperial College, Hammersmith Campus, London, W12 0NN, UK.
Trillium ChangStanford Law School, 559 Nathan Abbott Way, Stanford, CA, 94305, USA.
Graham MartinTHIS Institute, Department of Public Health and Primary Care, University of Cambridge, Cambridge Biomedical Campus, Clifford Allbutt Building, Cambridge, CB2 0AH, UK.
Alexandros GeorgiadisICON plc, Cambridge Biomedical Campus, Clifford Allbutt Building, Cambridge, London, CB2 0AH, UK.
Veronica HeneyWellcome Centre for Cultures and Environments of Health, University of Exeter, Queens Drive, Exeter, EX4 4PZ, UK.
Sarah ChewSocial Science Applied to Healthcare Improvement Research (SAPPHIRE) Group, Department of Health Sciences, University of Leicester, George Davies Centre, University Road, Leicester, Leicester, LE1 7RH, UK.
Aricca Van CittersThe Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth College, Level 5, WTRB, 1 Medical Center Drive, Lebanon, NH, 03756, USA.
Kathryn A SabadosaCystic Fibrosis Foundation, 4550 Montgomery Ave., Suite 1100 N, Bethesda, MD, 20814, USA.
Eugene C NelsonThe Dartmouth Institute for Health Policy & Clinical Practice, Dartmouth College, Level 5, WTRB, 1 Medical Center Drive, Lebanon, NH, 03756, USA.

Funding

Department of Health NF-SI-0617-10026Wellcome TrustWellcome Trust WT097899
6 · The paper itself

Abstract

backgroundNew opportunities to record, collate, and analyze routine patient data have prompted optimism about the potential of learning health systems. However, real-life examples of such systems remain rare and few have been exposed to study. We aimed to examine the views of design stakeholders on designing and implementing a US-based registry-enabled care and learning system for cystic fibrosis (RCLS-CF).

methodsWe conducted a two-phase qualitative study with stakeholders involved in designing, implementing, and using the RCLS-CF. First, we conducted semi-structured interviews with 19 program personnels involved in design and delivery of the program. We then undertook 11 follow-up interviews. Analysis of interviews was based on the constant comparative method, supported by NVivo software.

resultsThe organizing principle for the RCLS-CF was a shift to more partnership-based relationships between patients and clinicians, founded in values of co-production, and facilitated by technology-enabled data sharing. Participants proposed that, for the system to be successful, the data it collects must be both clinically useful and meaningful to patients and clinicians. They suggested that the prerequisites included a technological infrastructure capable of supporting data entry and joint decision-making in an accessible way, and a set of social conditions, including willingness from patients and clinicians alike to work together in new ways that build on the expertise of both parties. Follow-up interviews highlighted some of the obstacles, including technical challenges and practical constraints on refiguring relationships between clinicians and patients.

conclusionsThe values and vision underlying the RCLS-CF were shared and clearly and consistently articulated by design stakeholders. The challenges to realization were often not at the level of principle, but were both practical and social in character. Lessons from this study may be useful to other systems looking to harness the power of "big data" registries, including patient-reported data, for care, research, and quality improvement.

Indexed as

Stakeholder ParticipationCystic FibrosisDecision Making, SharedHumansInformation TechnologyInterviews as TopicLearning Health SystemPatient ParticipationQualitative ResearchQuality ImprovementSocial EnvironmentUnited StatesCo-productionCystic fibrosisLearning health systemsProgram theoryQualitativeQuality improvementRegistriesReplication

Identifiers

PMID32143678
PMCPMC7060536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.